Detection of Radiation-Induced DNA Damage in Breast Cancer Patients by Using Gamma H2AX Biomarker: A Possible Correlation with Their Body Mass Index
- PMID: 35444787
- PMCID: PMC9015078
- DOI: 10.4103/genint.genint_1_22
Detection of Radiation-Induced DNA Damage in Breast Cancer Patients by Using Gamma H2AX Biomarker: A Possible Correlation with Their Body Mass Index
Abstract
Radiotherapy is one of the most important options for treating breast cancer in humans. The development of biomarkers to monitor radiosensitivity is scarce. The aim of this study is to investigate the γH2AX levels in the human blood samples 0.5 h after radiotherapy compared to the levels before radiotherapy in breast cancer patients in relation to their respective body mass index (BMI). Blood plasma samples were collected from a total of 20 breast cancer patients before and after radiotherapy to measure γH2AX levels with an antibody against γH2AX based on enzyme-linked immunosorbent assay technique. The median BMI of the patients was 30 kg/m2. γH2AX was differentially expressed in breast cancer patients before radiotherapy. γH2AX levels significantly increased in 14 patients after radiotherapy (P = 0.006), whereas γH2AX levels decreased in three patients after radiotherapy, and three patients were excluded. There was no correlation between γH2AX values after radiotherapy and BMI (P = 0.5, r = 0.1). Our results suggest that γH2AX can be used by ELISA technique to measure γH2AX in the blood plasma of breast cancer patients undergoing radiotherapy and can be considered a biomarker of radiosensitivity.
Keywords: Body mass index; DNA damage; H2AX; radiotherapy.
Copyright: © 2022 Genome Integrity.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
DNA repair foci and late apoptosis/necrosis in peripheral blood lymphocytes of breast cancer patients undergoing radiotherapy.Int J Radiat Biol. 2015;91(12):934-45. doi: 10.3109/09553002.2015.1101498. Epub 2015 Nov 4. Int J Radiat Biol. 2015. PMID: 26537244
-
Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci.Radiat Oncol. 2013 Apr 24;8:98. doi: 10.1186/1748-717X-8-98. Radiat Oncol. 2013. PMID: 23617930 Free PMC article.
-
The potential value of the neutral comet assay and γH2AX foci assay in assessing the radiosensitivity of carbon beam in human tumor cell lines.Radiol Oncol. 2013 Jul 30;47(3):247-57. doi: 10.2478/raon-2013-0045. eCollection 2013. Radiol Oncol. 2013. PMID: 24133390 Free PMC article.
-
Use of γH2AX and other biomarkers of double-strand breaks during radiotherapy.Semin Radiat Oncol. 2010 Oct;20(4):223-31. doi: 10.1016/j.semradonc.2010.05.004. Semin Radiat Oncol. 2010. PMID: 20832014 Review.
-
Persistent γH2AX: A promising molecular marker of DNA damage and aging.Mutat Res Rev Mutat Res. 2015 Oct-Dec;766:1-19. doi: 10.1016/j.mrrev.2015.07.001. Epub 2015 Jul 21. Mutat Res Rev Mutat Res. 2015. PMID: 26596544 Review.
Cited by
-
Dose-Dependent Effects of Radiation on Mitochondrial Morphology and Clonogenic Cell Survival in Human Microvascular Endothelial Cells.Cells. 2023 Dec 23;13(1):39. doi: 10.3390/cells13010039. Cells. 2023. PMID: 38201243 Free PMC article.
-
Flow cytometric assessment of DNA double-strand break and repair kinetics in prediction of intrinsic radiosensitivity.Iran J Basic Med Sci. 2022 Sep;25(9):1104-1109. doi: 10.22038/IJBMS.2022.65178.14350. Iran J Basic Med Sci. 2022. PMID: 36246068 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–86. - PubMed
-
- Rosenblatt E, Izewska J, Anacak Y, Pynda Y, Scalliet P, Boniol M, et al. Radiotherapy capacity in European countries: An analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol. 2013;14:e79–86. - PubMed
-
- Chua ML, Rothkamm K. Biomarkers of radiation exposure: Can they predict normal tissue radiosensitivity? Clin Oncol (R Coll Radiol) 2013;25:610–6. - PubMed
-
- Forker LJ, Choudhury A, Kiltie AE. Biomarkers of tumour radiosensitivity and predicting benefit from radiotherapy. Clin Oncol (R Coll Radiol) 2015;27:561–9. - PubMed
LinkOut - more resources
Full Text Sources